GRASSILLI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 4.892
EU - Europa 2.980
AS - Asia 2.278
SA - Sud America 330
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 3
Totale 10.555
Nazione #
US - Stati Uniti d'America 4.723
IT - Italia 904
SG - Singapore 839
DE - Germania 673
CN - Cina 489
RU - Federazione Russa 284
VN - Vietnam 271
HK - Hong Kong 256
BR - Brasile 249
SE - Svezia 247
GB - Regno Unito 189
IE - Irlanda 163
CA - Canada 136
UA - Ucraina 130
FR - Francia 90
IN - India 87
ID - Indonesia 66
DK - Danimarca 60
FI - Finlandia 59
AT - Austria 49
BD - Bangladesh 36
KR - Corea 35
TR - Turchia 33
IQ - Iraq 27
AR - Argentina 25
PK - Pakistan 25
JP - Giappone 22
NL - Olanda 22
PL - Polonia 18
SA - Arabia Saudita 18
ES - Italia 17
BE - Belgio 16
MX - Messico 16
CH - Svizzera 15
CO - Colombia 15
VE - Venezuela 13
MA - Marocco 12
ZA - Sudafrica 12
EU - Europa 11
PH - Filippine 11
UZ - Uzbekistan 11
KE - Kenya 10
LT - Lituania 10
CL - Cile 9
PY - Paraguay 8
EC - Ecuador 7
RS - Serbia 7
CZ - Repubblica Ceca 6
EG - Egitto 6
IR - Iran 5
LB - Libano 5
OM - Oman 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
HR - Croazia 4
IL - Israele 4
JO - Giordania 4
MU - Mauritius 4
MY - Malesia 4
NP - Nepal 4
BB - Barbados 3
ET - Etiopia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
PE - Perù 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
PT - Portogallo 2
SN - Senegal 2
SV - El Salvador 2
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
LI - Liechtenstein 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.555
Città #
Ann Arbor 1.313
Frankfurt am Main 535
Singapore 527
Ashburn 430
Milan 427
San Jose 361
Wilmington 245
Hong Kong 243
Chandler 159
Dublin 159
Fairfield 134
New York 116
Dearborn 114
Jacksonville 101
Houston 97
Woodbridge 91
Los Angeles 90
Ho Chi Minh City 83
The Dalles 77
Beijing 75
Santa Clara 75
Toronto 71
Chicago 68
Council Bluffs 68
Seattle 62
Hanoi 59
Dallas 57
Jakarta 57
Princeton 57
Cambridge 47
Shanghai 44
Mcallen 43
Vienna 41
Hefei 40
Boardman 33
Lauterbourg 32
Nanjing 30
Kent 29
Seoul 29
São Paulo 29
Guangzhou 27
Rome 25
Helsinki 24
London 24
Buffalo 22
Munich 22
Columbus 21
Brooklyn 19
Altamura 18
Tokyo 18
Lachine 17
Lawrence 16
Ottawa 16
Atlanta 15
Denver 15
Warsaw 15
Lissone 14
Orem 14
Shenyang 14
Brussels 13
Chennai 13
Moscow 13
Phoenix 13
Pune 13
Segrate 13
Turin 13
Zhengzhou 13
Montreal 12
Monza 12
San Diego 12
Amsterdam 11
Da Nang 11
Kunming 11
Manchester 11
Nanchang 11
San Francisco 11
Tashkent 11
Dhaka 10
Lappeenranta 10
Medellín 10
Sacramento 10
Auburn Hills 9
Changsha 9
Dong Ket 9
Edmonton 9
Haiphong 9
Nuremberg 9
Tianjin 9
Zurich 9
Baghdad 8
Hebei 8
Jinan 8
Boston 7
Karachi 7
Mexico City 7
Nairobi 7
Poplar 7
Rio de Janeiro 7
Biên Hòa 6
Caracas 6
Totale 7.111
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 653
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy 626
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 608
Combinations of a btk inhibitor and fluorouracil for treating cancers 578
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 566
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 538
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 526
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 491
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 451
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 443
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 375
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 368
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 321
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 298
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 292
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 289
Methods for determining the sensitivity or resistance of cancer cells to at least one anticancer drug and/or therapeutically active molecule 272
Identifying novel actionable targets in colon cancer 257
Emerging actionable targets to treat therapy-resistant colorectal cancers 250
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 247
Isoform of bruton's tyrosine kinase (BTK) protein 222
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression 217
NEW ISOFORM OF BRUTON’S TYROSINE KINASE (BTK) PROTEIN 217
Modulator compounds of the drug resistance in epithelial tumour cells 211
Isoform of bruton's tyrosine kinase (BTK) protein 209
Isoform of Bruton's tyrosine kinase (BTK) protein 209
Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours 205
Modulator compounds of the drug resistance in epithelial tumour cells 192
Modulator compounds of the drug resistance in epithelial tumour cells 189
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 172
BTK, the new kid on the (oncology) block? 168
Editorial: Targeting Bruton Tyrosine Kinase 162
Modulator compound of the drug resistance in epithelial tumor cells 157
Targeting p65BTK for treating solid cancers 147
Totale 11.126
Categoria #
all - tutte 33.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.617


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022639 90 83 96 57 24 40 25 16 18 12 79 99
2022/20231.112 126 288 145 115 85 142 34 58 52 13 24 30
2023/2024650 32 22 27 61 57 153 110 37 15 43 7 86
2024/20251.414 82 131 101 63 117 75 85 46 142 238 120 214
2025/20263.667 423 192 277 355 485 212 651 132 280 323 159 178
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 11.126